iRhythm Holdings, Inc. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
iRhythm Holdings, Inc. (IRTC) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-02-19
- iRhythm Holdings, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2024-12-31 was $4.01M.
- iRhythm Holdings, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-12-31 was -$117.00K, a 685.00% decline year-over-year.
- iRhythm Holdings, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-09-30 was $4.52M.
- iRhythm Holdings, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-06-30 was $0.00.
- iRhythm Holdings, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- iRhythm Holdings, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $4.01M, a 8.95% decline from fiscal 2023.
- iRhythm Holdings, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $4.40M, a 42.71% decline from fiscal 2022.
- iRhythm Holdings, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $7.69M, a 16.02% increase from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-19 | |||
| 2024-12-31 | $4.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $4.01M 10-K · filed 2026-02-19 | ||
| 2024-09-30 | $0.00 10-Q · filed 2024-10-30 | |||
| 2023-12-31 | -$117.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $4.40M derived: sum of 2 quarters · filed 2026-02-19 | $4.40M derived: sum of 3 quarters · filed 2026-02-19 | $4.40M 10-K · filed 2026-02-19 |
| 2023-09-30 | $4.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $4.52M derived: sum of 2 quarters · filed 2024-10-30 | $4.52M 10-Q · filed 2024-10-30 | $4.54M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $0.00 10-Q · filed 2023-08-04 | $20.00K derived: sum of 3 quarters · filed 2025-02-20 | $20.00K derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-04 | $20.00K derived: sum of 2 quarters · filed 2025-02-20 | $20.00K derived: sum of 3 quarters · filed 2025-02-20 | $20.00K derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $20.00K derived: sum of 2 quarters · filed 2025-02-20 | $20.00K derived: sum of 3 quarters · filed 2025-02-20 | $7.69M 10-K · filed 2025-02-20 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $0.00 derived: sum of 2 quarters · filed 2023-11-02 | $7.67M 10-Q · filed 2023-11-02 | $7.85M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $7.67M 10-Q · filed 2023-08-04 | $7.85M derived: sum of 3 quarters · filed 2024-02-22 | $8.24M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $7.67M 10-Q · filed 2023-05-04 | $7.85M derived: sum of 2 quarters · filed 2024-02-22 | $8.24M derived: sum of 3 quarters · filed 2024-02-22 | $8.53M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $182.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $578.00K derived: sum of 2 quarters · filed 2024-02-22 | $868.00K derived: sum of 3 quarters · filed 2024-02-22 | $6.63M 10-K · filed 2024-02-22 |
| 2021-09-30 | $396.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $686.00K derived: sum of 2 quarters · filed 2022-11-04 | $6.44M 10-Q · filed 2022-11-04 | $6.44M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $290.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $6.05M 10-Q · filed 2022-08-05 | $6.05M derived: sum of 3 quarters · filed 2023-02-23 | $6.05M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $5.76M 10-Q · filed 2022-05-06 | $5.76M derived: sum of 2 quarters · filed 2023-02-23 | $5.76M derived: sum of 3 quarters · filed 2023-02-23 | $5.76M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $0.00 derived: sum of 2 quarters · filed 2023-02-23 | $0.00 derived: sum of 3 quarters · filed 2023-02-23 | $621.00K 10-K · filed 2023-02-23 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $0.00 derived: sum of 2 quarters · filed 2021-11-05 | $621.00K 10-Q · filed 2021-11-05 | $311.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $621.00K 10-Q · filed 2021-08-09 | $311.00K derived: sum of 3 quarters · filed 2022-02-28 | $89.48M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $621.00K 10-Q · filed 2021-05-10 | $311.00K derived: sum of 2 quarters · filed 2022-02-28 | $89.48M derived: sum of 3 quarters · filed 2022-02-28 | $89.48M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$310.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $88.86M derived: sum of 2 quarters · filed 2022-02-28 | $88.86M derived: sum of 3 quarters · filed 2022-02-28 | $88.86M 10-K · filed 2022-02-28 |
| 2019-09-30 | $89.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $89.17M derived: sum of 2 quarters · filed 2020-11-06 | $89.17M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $0.00 10-Q · filed 2020-08-07 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-08 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |